We’re excited to bring you the November edition of The Action Report. This month has been filled with activity, culminating in the Coalition’s Annual Meeting last week. Below, you’ll find highlights from the meeting and recent member actions, as well as a new Leading By Example spotlight of 2024 Leadership Award winner Glen Peitrandoni from Avita Care Solutions.
On Thursday, November 21st, over 80 business leaders, strategic partners, public health and community leaders gathered at Emory University’s Rollins School of Public Health in Atlanta to make meaningful connections, celebrate achievements of the Coalition, and collaborate on strategies and action plans for the coming year.
During the meeting, the Coalition released the 2024 Impact Report highlighting the achievements of the past year. Director of The White House Office of National AIDS Policy Francisco Ruiz and Director of CDC's Division of HIV Prevention Dr. Robyn Neblett-Fanfair also shared an update on the nation’s progress toward ending the HIV epidemic and the importance of ongoing private-sector engagement.
At the event reception, attendees celebrated the first annual 2024 U.S. Business Action to End HIV Award recipients:
🏆 The Action Award was given to Avita Care Solutions, Chevron, CVS Health, Gilead Sciences, Healthvana, Match Group, MISTR, Paramount Pictures, ViiV Healthcare, and Walgreens for completing all six corporate actions as part of Coalition membership.
🏆 The Corporate Leadership Award was given to Mercer for raising awareness of HIV’s economic and human impact.
🏆 The Leadership Award was awarded to Glen Pietrandoni of Avita Care Solutions for his career-long dedication to advancing HIV care and advocacy.
It is remarkable what this Coalition has accomplished over the last two years, and it shows what is possible when passionate and dedicated leaders work together to accelerate efforts toward a common goal.
Check out the press release and post from HIV.gov, recapping highlights from the event and priorities for the year ahead.
Attendees learned about the significance of HIV awareness and how they can help reduce stigma surrounding HIV in their workplaces and communities, and were invited to join the upcoming LA chapter launch.
“Leading by Example” is a series from U.S. Business Action to End HIV highlighting inspiring business leaders who are accelerating progress toward an end to the HIV epidemic in the U.S.
Glen Pientrandoni
Chief Advocacy Officer
Avita Care Solutions
This month, we are pleased to spotlight Glen Pietrandoni, Chief Advocacy Officer at Avita Care Solutions. Glen was the recent recipient of the U.S. Business Action to End HIV 2024 Leadership Award.
Why do you believe it's important for businesses to play a role in our nation's efforts to end the HIV epidemic?
We know that stigma, staggering health inequities, and social determinants of health cause specific groups to bear the burden of HIV/AIDS more than others. Even though we’ve been battling the virus for a long time, we must constantly innovate personalized ways to engage with people and offer them choices on how to prevent and treat HIV.
Businesses play a vital role in engaging with the communities they serve, as well as the people and families they employ. Employers are often also responsible for providing healthcare to their team members. As such, they are uniquely positioned to help educate their team members, communities, and clients about HIV treatment and prevention. I believe our nation is full of companies that, like Avita, want to do the right thing. It’s good for the health and engagement of their workforce, and it’s also just good for business. The public embraces businesses that care about their customers and communities by choosing them over their competitors.
You have a long history in the fight against HIV. What are you most hopeful about today, and what critical work is there still left to do?
I was a pharmacist on the frontlines of community health during the earliest days of the HIV epidemic, long before the life-saving treatments and destigmatization efforts available today existed. Since the beginning, I’ve made a personal commitment to offering culturally competent patient care and educating other pharmacists about our critical role in ensuring patient access and adherence to HIV treatment and prevention services. While in 2024 there are powerful medications and prevention options that put us much closer to ending HIV, the opportunity to benefit from these programs is still woefully out of reach for too many patients.
What advice would you give to other corporate leaders considering taking action on HIV?
I’d encourage corporate leaders to prioritize educating their team members about healthcare and wellness opportunities. Of course, this includes HIV prevention and treatment, but also other topics, including achieving a better quality of life through optimal diet, exercise, and mental health.
Check out Glen’s full profile on the Health Action Alliance website here.
Thank you for your commitment and leadership. Let's keep up the momentum!
Sign up for our newsletter to keep updated on HAA’s latest initiatives, insights and recommendations, and be first to receive new resources and event invitations.
Sign up